New drug application An application to the fDA for approval to market a drug in the U.S. The FDA determines if a protein pharmaceutical is considered a drug or a biologic and whether an NDA or a pLA, respectively, should be filed to obtain marketing approval.

Please contribute to this project, if you have more information about this term feel free to edit this page

This page was last modified on 3 October 2005, at 21:16. This page has been accessed 2,100 times. 
What links here | Related changes | Permanent link